FAQ

For Healthcare Professionals & Consumers

PRODUCT DESCRIPTION

Q. What is Soltel?
A. Soltel is a salmeterol pMDI. It dispenses 120 actuations per device.

Q. Is the Soltel inhaler compatible with a universal spacer?
A. Soltel is compatible with a Volumatic® spacer.

Q. Are the therapeutic indications for Soltel the same as for other salmeterol products?

A.The therapeutic indications for Soltel are:

  • Regular, symptomatic add-on treatment of reversible airways obstruction in patients with asthma, including those with nocturnal asthma who are inadequately controlled on inhaled corticosteroids in accordance with current treatment guidelines; and
  • Treatment of chronic obstructive pulmonary disease (COPD).
2016-12-01_17h53_34

 

Q. Is Soltel indicated for use in children?
A. Soltel should not be used in children 12 years of age or younger, owing to the fact that safety and efficacy in this age range have not been demonstrated.

Q. Does Soltel contain ethanol?
A. Soltel does contain ethanol.

Q. What is the shelf life of Soltel?
A. The shelf life of Soltel is two years.

Q. Can patients with a peanut or soya allergy use Soltel?
A. Soltel contains soya lecithin, and is therefore unsuitable for use in patients with a peanut or soya allergy.

Q. What are the storage requirements for Soltel?
A. Soltel should be stored in temperatures lower than 30ºC, and should never be frozen. The canister contains a pressurised liquid, and should therefore not be exposed to temperatures higher than 50ºC. Do not puncture, break or burn, even when apparently empty.

Reporting of suspected adverse reactions
Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse event should also be reported to Kent Pharmaceuticals
on 01233 506 574 or medinfo@kentpharm.co.uk

UK18/03/01. Date of preparation: April 2018